[Edaily Reporter Shin Young-bin] #Angelo Robotics, a company specializing in wearable robots, held a kickoff meeting for the “Brain-to-Robot” development project—a cross-ministerial flagship initiative—and has officially begun the development and commercialization of next-generation human-centered robot technology.

Angel Robotics announced on the 18th that it held the kickoff meeting for the Brain-to-Robot flagship project and shared a next-generation commercialization roadmap spanning from technology development to the commercialization of medical devices.

The inter-ministerial Brain-to-Robot Flagship Project aims to realize bidirectional brain-to-robot technology that reads a person’s behavioral intentions from the brain to control a robot and transmits sensory information acquired by the robot back to the person. The project will run for seven years, from 2026 to 2032.

Angel Robotics, as the lead organization for this project, is spearheading the entire consortium. The company is responsible for integrating Brain-to-Robot technology into actual medical devices and commercializable systems.

This kickoff meeting was organized to share the project’s ultimate goals and annual objectives, as well as to align the overall direction of the project—including the robot, brain chip, regulatory approval for combined medical devices, and user experience design. Angel Robotics shared with the consortium a business strategy that goes beyond simple research and development, focusing on the commercialization of actual medical devices and market entry.

During the meeting, Director Gong Gyeong-cheol of Angel Robotics, the project’s general manager, explained the project’s ultimate goals, annual implementation plans, and key research directions related to robotics. Director Gong shared the development direction of exoskeleton robot technology and key research tasks for implementing “brain-to-robot” communication, emphasizing that this project is a national challenge to build a next-generation human-centered robot platform that goes beyond the development of individual technologies.

Next, Professor Jang Kyung-in presented the progress of brain chip research, and Director Jang Ho-sik introduced the GMP and regulatory approval strategies for modular medical devices. During the afternoon session, discussions focused on user experience design to address unmet needs of both users and medical staff.

Through this project, Angel Robotics plans to expand its existing wearable robot technology into the brain-to-robot domain. In particular, the company will pursue the commercialization of next-generation medical devices and human-centered robot platforms based on bidirectional control technology, which enables robots to understand human behavioral intentions and relay sensory information back to the user.

Director Gong explained that this project marks a turning point for Angel Robotics, expanding its world-class wearable robot technology into the next-generation “brain-to-robot” domain. He emphasized that this project must go beyond mere research and lead to the actual commercialization of medical devices and the establishment of a next-generation human-centered platform.

Jo Nam-min, CEO of Angel Robotics, stated, “This project is part of the process of building a next-generation human-centered platform that fundamentally understands and extends human movement,” adding, “Angel Robotics will play a key role in helping Korea emerge as a leading nation in next-generation robotics technology.”